ClinicalTrials.Veeva

Menu

Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly (IRIDIA)

A

Assistance Publique - Hôpitaux de Paris

Status

Terminated

Conditions

Myocardial Ischemia

Treatments

Other: Diagnosis strategy and subsequent therapeutic reassessment
Other: diagnosis reassessment

Study type

Interventional

Funder types

Other

Identifiers

NCT00224575
AOM03099

Details and patient eligibility

About

Despite the effectiveness of beta-blockers and antiplatelet agents for secondary prevention of coronary heart disease, this treatments are underused in the elderly because of diagnosis uncertainty and underuse of efficient treatment.

in a first time, diagnosis reassessment with invasive technique if necessary. in a second time, treatment reassessment.

Full description

not desired

Enrollment

260 patients

Sex

All

Ages

75+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients 75 of age or older hospitalized in a geriatric service and suspect of coronary heart disease

Exclusion criteria

  • acute myocardial infarction

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

260 participants in 1 patient group

1
Experimental group
Description:
Diagnosis strategy and subsequent therapeutic reassessment All patients are in that arms. They all receive the diagnosis reassessment strategy.
Treatment:
Other: Diagnosis strategy and subsequent therapeutic reassessment
Other: diagnosis reassessment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems